Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Sensation Disorders D012678 2 associated lipids
Ileus D045823 3 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Teratocarcinoma D018243 7 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Retinal Detachment D012163 10 associated lipids
Cardiomyopathies D009202 10 associated lipids
Influenza, Human D007251 11 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Lung Injury D055370 14 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Tuberculosis D014376 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Anemia D000740 21 associated lipids
Sarcoma 180 D012510 21 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Pulmonary Edema D011654 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Fibrosis D005355 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Pandey S and Assmann SM The Arabidopsis putative G protein-coupled receptor GCR1 interacts with the G protein alpha subunit GPA1 and regulates abscisic acid signaling. 2004 Plant Cell pmid:15155892
Taha TA et al. Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. 2004 Biochim. Biophys. Acta pmid:15158755
Duong CQ et al. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages. 2004 Biochim. Biophys. Acta pmid:15158762
Zhou H and Murthy KS Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2. 2004 Am. J. Physiol., Cell Physiol. pmid:15075212
Barnes PJ Ceramide lances the lungs. 2004 Nat. Med. pmid:14760419
Hung RJ et al. Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts. 2004 Am. J. Physiol., Cell Physiol. pmid:15075215
Wang W et al. Physiological sphingosine 1-phosphate requirement for optimal activity of mouse CD4+ regulatory T Cells. 2004 FASEB J. pmid:15084513
Renkl A et al. Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells. 2004 Int. J. Mol. Med. pmid:14719124
Jin ZQ et al. Sphingosine kinase activation mediates ischemic preconditioning in murine heart. 2004 Circulation pmid:15451787
Shimamura K et al. Expression of adhesion molecules by sphingosine 1-phosphate and histamine in endothelial cells. 2004 Eur. J. Pharmacol. pmid:14975703
Yatomi Y et al. Sphingosine 1-phosphate breakdown in platelets. 2004 J. Biochem. pmid:15625319
Galaria II et al. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. 2004 J. Surg. Res. pmid:15555614
Shida D et al. Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells. 2004 FEBS Lett. pmid:15556605
Langlois S et al. Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. 2004 Blood pmid:15070679
Ochi S et al. Clostridium perfringens alpha-toxin activates the sphingomyelin metabolism system in sheep erythrocytes. 2004 J. Biol. Chem. pmid:14702348
vom Dorp F et al. Inhibition of phospholipase C-epsilon by Gi-coupled receptors. 2004 Cell. Signal. pmid:15157671
Allende ML et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. 2004 J. Biol. Chem. pmid:15459201
Yamanaka M et al. Sphingosine kinase 1 (SPHK1) is induced by transforming growth factor-beta and mediates TIMP-1 up-regulation. 2004 J. Biol. Chem. pmid:15485866
Alewijnse AE et al. Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. 2004 Br. J. Pharmacol. pmid:15504747
Mo FM et al. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. 2004 Eur. J. Pharmacol. pmid:15063151
Roth Z and Hansen PJ Sphingosine 1-phosphate protects bovine oocytes from heat shock during maturation. 2004 Biol. Reprod. pmid:15317688
Hemmings DG et al. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. 2004 Br. J. Pharmacol. pmid:15326035
McVerry BJ et al. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. 2004 Am. J. Respir. Crit. Care Med. pmid:15282202
Ogretmen B and Hannun YA Biologically active sphingolipids in cancer pathogenesis and treatment. 2004 Nat. Rev. Cancer pmid:15286740
Waeber C et al. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors. 2004 Jul-Aug Drug News Perspect. pmid:15334188
De Luca T et al. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis. 2005 Biofactors pmid:16873929
Lindner K et al. Ceramide alters endothelial cell permeability by a nonapoptotic mechanism. 2005 Br. J. Pharmacol. pmid:15735657
Ikeda M et al. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme. 2005 Biochem. Biophys. Res. Commun. pmid:15737611
Yabu T et al. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. 2005 Blood pmid:15741222
Kee TH et al. Sphingosine kinase signalling in immune cells. 2005 Clin. Exp. Pharmacol. Physiol. pmid:15743396
Suomalainen L et al. Sphingosine-1-phosphate inhibits nuclear factor kappaB activation and germ cell apoptosis in the human testis independently of its receptors. 2005 Am. J. Pathol. pmid:15743789
Pilorget A et al. Inhibition of angiogenic properties of brain endothelial cells by platelet-derived sphingosine-1-phosphate. 2005 J. Cereb. Blood Flow Metab. pmid:15829917
Bolick DT et al. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:15761190
Blom T et al. Enhancement of intracellular sphingosine-1-phosphate production by inositol 1,4,5-trisphosphate-evoked calcium mobilisation in HEK-293 cells: endogenous sphingosine-1-phosphate as a modulator of the calcium response. 2005 Cell. Signal. pmid:15763425
Itagaki K et al. Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils. 2005 J. Leukoc. Biol. pmid:15522918
McVerry BJ and Garcia JG In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. 2005 Cell. Signal. pmid:15494205
Waters CM et al. c-Src is involved in regulating signal transmission from PDGFbeta receptor-GPCR(s) complexes in mammalian cells. 2005 Cell. Signal. pmid:15494217
Minnear FL et al. Sphingosine 1-phosphate prevents platelet-activating factor-induced increase in hydraulic conductivity in rat mesenteric venules: pertussis toxin sensitive. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15778280
Hsiao SH et al. Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings. 2005 Toxicol. Sci. pmid:15829618
Geoffroy K et al. Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. 2005 FEBS Lett. pmid:15710421
Takashiro Y et al. Involvement of p38 MAP kinase-mediated cytochrome c release on sphingosine-1-phosphate (S1P)- and N-monomethyl-S1P-induced cell death of PC12 cells. 2005 Biochem. Pharmacol. pmid:15907808
Halin C et al. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. 2005 Blood pmid:15870184
Takeshita A et al. Sphingosine 1-phosphate acts as a signal molecule in ceramide signal transduction of TNF-alpha-induced activator protein-1 in osteoblastic cell line MC3T3-E1 cells. 2005 J Oral Sci pmid:15881228
Sauer B et al. Sphingosine 1-phosphate is involved in cytoprotective actions of calcitriol in human fibroblasts and enhances the intracellular Bcl-2/Bax rheostat. 2005 Pharmazie pmid:15881612
Ma Y et al. Sphingosine activates protein kinase A type II by a novel cAMP-independent mechanism. 2005 J. Biol. Chem. pmid:15883165
Tani M et al. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. 2005 J. Lipid Res. pmid:16061940
Yin F and Watsky MA LPA and S1P increase corneal epithelial and endothelial cell transcellular resistance. 2005 Invest. Ophthalmol. Vis. Sci. pmid:15914605
Wu WT et al. Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells. 2005 Endocrinology pmid:15878967
Long J et al. Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. 2005 Biochem. J. pmid:15960610
Malchinkhuu E et al. Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells. 2005 Oncogene pmid:16007180